COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Fulfilling Supply Commitments with Provincial Adult-Use Cannabis Shipments
07/11/2018
Emerald delivers first shipments to British Columbia and Newfoundland and Labrador VICTORIA, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) has [...]
Clementia Reports Third Quarter 2018 Operating Results and Pipeline Updates
07/11/2018
Recent FDA Meeting Identifies Path Towards NDA Submission in the Second Half of 2019 Financing Raises $75 million to Support a Potential Commercial Launch MONTREAL, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Clementia [...]
Clementia présente ses résultats d’exploitation pour le troisième trimestre de 2018, ainsi qu’une mise à jour de son portefeuille de produits
07/11/2018
Une rencontre récente avec la FDA ouvre la voie à la soumission d’une NDA au second semestre de 2019 Une activité de financement rapporte 75 M$ pour la réalisation d’un lancement commercial potentiel MONTRÉAL, 07 nov. [...]
Foamix Announces Positive Topline Results from Phase 3 Program Evaluating FMX103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea
07/11/2018
FMX103 Demonstrated Highly Statistically Significant Improvement Compared with Vehicle in Both Co-Primary Efficacy Endpoints Conference Call and Webcast Today at 8:30 a.m. ET REHOVOT, Israel and BRIDGEWATER, N.J., Nov. [...]
A Q&A Session With RavenQuest CEO George Robinson
07/11/2018
VANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) We’re heading swiftly through the final quarter of 2018 and [...]
Momenta Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today reported its financial results for the third quarter ended September 30, 2018 and provided a corporate update. “We [...]
Achillion Reports Third Quarter 2018 Financial Results
07/11/2018
- Completed enrollment of Phase 2 clinical trial of ACH-4471 in PNH as monotherapy - - Interim data and strategic update planned for December 17, 2018 – - September 30, 2018 cash & securities position of $283 [...]
Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
07/11/2018
WATERTOWN, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Immunicum AB (publ) Interim Report July - September 2018
07/11/2018
Press Release 7 November 2018 Immunicum AB (publ) Interim Report July - September 2018 Positive preclinical results presented at ESMO Significant Events During the Third Quarter Immunicum announced protocol approval by [...]
Rule 2.9 Announcement
07/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 November 2018 [...]
Sensorion Announces Presentation of SENS-401 Poster at Society for Neuroscience 2018 Annual Meeting
07/11/2018
Preclinical data suggest efficacy of SENS-401 is not affected by concomitant administration of a corticosteroid Adds to evidence supporting use of SENS-401 in sudden sensorineural hearing loss (SSNHL) Phase II trial of [...]
Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 raised
07/11/2018
Valby, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Financial report for the period 1 January to 30 September 2018 Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 [...]
MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices
07/11/2018
NEWS RELEASE REGULATED INFORMATION Real-world study shows that SelectMDx helps urologists more confidently determine the need for an initial prostate biopsy IRVINE, CA, and HERSTAL, BELGIUM - 07.00 CEST, 7 November 2018 [...]
MDxHealth (R): SelectMDx améliore la prise de décision en matière de biopsie de la prostate dans les cabinets d'urologie
07/11/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES Une enquête menée en situation réelle prouve que le test SelectMDx aide les urologues à mieux établir le besoin de procéder ou non à une biopsie de la prostate initiale [...]
ObsEva SA to Participate in November Investor Conferences
07/11/2018
Geneva, Switzerland and Boston, MA – November 7, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada.
07/11/2018
Amsterdam, the Netherlands - 7 November 2018 Esperite's (Euronext: ESP) biotech company The Cell Factory has obtained the patent for the use of extracellular vesicles (EVs) in the treatment of acute and chronic [...]
Bone Therapeutics Business Update for Third Quarter 2018
07/11/2018
Regulated information Positive efficacy and safety results in ALLOB Delayed Union Phase I/II trial, supporting next stage in clinical development Manufacturing process optimisation implemented for allogeneic platform [...]
Bone Therapeutics publie son rapport d’activité du troisième trimestre 2018
07/11/2018
Information réglementée Résultats positifs d’efficacité et de sécurité de l’étude de Phase I/II avec ALLOB dans les fractures avec retard de consolidation, encourageant la poursuite du développement clinique Mise en [...]
XORTX Announces Appointment of CFO
07/11/2018
CALGARY, Alberta, Nov. 06, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]

Pages